Next Generation Robotic System for Supervised-Autonomous Bowel Anastomosis
用于监督自主肠吻合术的下一代机器人系统
基本信息
- 批准号:10910494
- 负责人:
- 金额:$ 74.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdoptionAnastomosis - actionAnimalsArtificial IntelligenceCardiacCardiac Surgery proceduresCardiovascular systemChildhoodClinicalClinical TrialsColectomyColonColorectalColorectal CancerComplexComplicationDataEndoscopesEndoscopyEnsureEnvironmentExcisionExtravasationFamily suidaeFeasibility StudiesGoalsGynecologicHealthHourHumanIncidenceIntelligenceInterventionIntestinesLaparoscopic Surgical ProceduresMalignant NeoplasmsMedicalMethodsMorbidity - disease rateOperative Surgical ProceduresOptical Coherence TomographyOutcomePatientsPediatric Surgical ProceduresPeripheralPilot ProjectsProceduresQuality of lifeReconstructive Surgical ProceduresResearchRobotRoboticsRuptureSafetySchemeStenosisStructureSurgeonSurgical suturesSystemTechniquesTechnologyTeleroboticsTestingThree-Dimensional ImagingTimeTissuesTrainingTransplantationUrologic Surgical ProceduresVisceralVisionVisual Fieldsadjudicationcurative treatmentsergonomicsexperienceexperimental studyfirst-in-humanfunctional improvementgastrointestinalimaging systemimprovedin vivominiaturizeminimally invasivemortalitynext generationnovelpatient safetypreclinical studyprospectiverobot assistancerobot controlrobotic systemskillssoft tissuesuccesstechnology developmentteleoperationtissue injurytissue phantomtoolurologic
项目摘要
Project Summary:
The goal of this project is to establish a new medical robot and surgical paradigm to perform clinical colonic
anastomosis with shared control. We will develop and evaluate novel miniaturized functional 3D imaging, artificial
intelligence (AI) based real time soft tissue tracking, and fail-safe autonomous control strategies that enable first
in human autonomous robotic soft tissue surgery. The long-term goal of this proposal is to reduce the
complication rates and improve functional outcomes of bowel anastomoses and other soft tissue surgeries
independent of surgeon’s experience. Anastomoses are critical and challenging procedures performed over a
million times per year in the US. However, up to 19% of gastrointestinal anastomoses are complicated by
leakage, strictures, and stenosis, and anastomotic complications significantly increase patient mortality up to ten
times. Recent key advances in surgery such as progressively more minimally invasive surgery (MIS) and robot-
assisted surgery (RAS) using a tele-operated da Vinci robot have not addressed the critical factors influencing
anastomotic outcome, and the overall anastomotic complication rates remain unchanged. Autonomous robotic
surgery systems have the potential to significantly improve efficiency, safety, and consistency over current tele-
operated RAS. Autonomous robotic soft tissue surgery is yet to be demonstrated in humans due to a lack of (a)
accurate 3D endoscopic vision, (b) robust markerless soft tissue tracking, and (c) fail safe autonomous control.
To address the clinical need for autonomous robotic suturing platforms, we developed a supervised autonomous
robotic system for guiding reconstructive bowel anastomosis. We propose to conduct first-in-human pilot studies
of an autonomous robotic suturing platform. Because complications from bowel anastomoses can be
catastrophic, we implement a stepwise gradual increase of complexity starting with open overstitching of the
closure of a common enterotomy and building up to laparoscopic colectomy to ensure patient safety. We
hypothesize that autonomous robotic soft tissue surgery is feasible in humans and will perform the task of
laparoscopic colectomy with better accuracy and efficiency over current tele-robotic RAS technology. The
following four specific aims will enable the development of this technology and demonstrate clinical feasibility.
We will develop miniaturized functional 3D imaging and tissue health sensing (Aim 1), AI based markerless
tissue tracking (Aim 2), fail-safe autonomous control strategies (Aim 3), and demonstrate first in human
autonomous soft tissue surgery in the form of common enterotomy closures (Aim 4). Beyond intestinal
anastomosis, adoption of this approach could be beneficial in all soft tissue MIS and RAS tasks requiring
precision and maneuverability, including complex pediatric, urological, and cardiac surgery.
项目概要:
该项目的目标是建立一种新的医疗机器人和手术范例来执行临床结肠手术
我们将开发和评估新型微型功能性 3D 成像、人工吻合术。
基于智能(AI)的实时软组织跟踪和故障安全自主控制策略,使第一个
该提案的长期目标是减少人类自主机器人软组织手术的成本。
并发症发生率并改善肠吻合术和其他软组织手术的功能结果
吻合术是一项关键且具有挑战性的手术,与外科医生的经验无关。
在美国每年有 19% 的胃肠道吻合术发生复杂化。
渗漏、狭窄和狭窄以及吻合口并发症显着增加患者死亡率高达 10
手术方面最近取得的重大进展,例如微创手术 (MIS) 和机器人手术。
使用遥控达芬奇机器人的辅助手术(RAS)尚未解决关键影响因素
吻合结果和总体吻合并发症率保持不变。
与当前的远程手术系统相比,手术系统有可能显着提高效率、安全性和一致性。
由于缺乏 (a),自主机器人软组织手术尚未在人类身上得到证实。
准确的 3D 内窥镜视觉,(b) 强大的无标记软组织跟踪,以及 (c) 故障安全自主控制。
为了满足自主机器人缝合平台的临床需求,我们开发了一种有监督的自主机器人缝合平台
用于重建肠吻合术的机器人引导系统我们建议进行首次人体试点研究。
因为肠吻合可能会引起并发症。
灾难性的,我们从开放的过度缝合开始逐步增加复杂性
关闭普通肠切开术并进行腹腔镜结肠切除术,以确保患者安全。
自主机器人软组织手术在人类中是可行的,并将执行以下任务
腹腔镜结肠切除术比当前的远程机器人 RAS 技术具有更高的准确性和效率。
以下四个具体目标将促进该技术的发展并证明临床有效性。
我们将开发小型化功能性 3D 成像和组织健康传感(目标 1)、基于人工智能的无标记技术
组织跟踪(目标 2)、故障安全自主控制策略(目标 3),并首次在人体中进行演示
以常见肠切开术闭合形式进行自主软组织手术(目标 4)。
吻合术,采用这种方法可能有益于所有需要的软组织 MIS 和 RAS 任务
精确性和可操作性,包括复杂的儿科、泌尿外科和心脏手术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Harrison Hsieh其他文献
Michael Harrison Hsieh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Harrison Hsieh', 18)}}的其他基金
Developing a Next Generation Mouse Model of Urogenital Schistosomiasis Through Ultrasound-Guided Percutaneous Bladder Wall Injection of Schistosoma haematobium Eggs
通过超声引导经皮膀胱壁注射埃及血吸虫卵开发下一代泌尿生殖血吸虫病小鼠模型
- 批准号:
10041747 - 财政年份:2020
- 资助金额:
$ 74.83万 - 项目类别:
Developing a Next Generation Mouse Model of Urogenital Schistosomiasis Through Ultrasound-Guided Percutaneous Bladder Wall Injection of Schistosoma haematobium Eggs
通过超声引导经皮膀胱壁注射埃及血吸虫卵开发下一代泌尿生殖血吸虫病小鼠模型
- 批准号:
10171777 - 财政年份:2020
- 资助金额:
$ 74.83万 - 项目类别:
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes
IPSE(一种泌尿生殖寄生虫衍生的宿主调节蛋白)对膀胱过敏综合征的治疗利用
- 批准号:
10124792 - 财政年份:2017
- 资助金额:
$ 74.83万 - 项目类别:
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes
IPSE(一种泌尿生殖寄生虫衍生的宿主调节蛋白)对膀胱过敏综合征的治疗利用
- 批准号:
9918915 - 财政年份:2017
- 资助金额:
$ 74.83万 - 项目类别:
Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes
IPSE(一种泌尿生殖寄生虫衍生的宿主调节蛋白)对膀胱过敏综合征的治疗利用
- 批准号:
9288039 - 财政年份:2017
- 资助金额:
$ 74.83万 - 项目类别:
Defining the Immunomodulatory Niche of Schistosoma haematobium IPSE
埃及血吸虫 IPSE 免疫调节生态位的定义
- 批准号:
9107658 - 财政年份:2015
- 资助金额:
$ 74.83万 - 项目类别:
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk
泌尿生殖上皮-益生菌相互作用的雌激素调节
- 批准号:
8666744 - 财政年份:2010
- 资助金额:
$ 74.83万 - 项目类别:
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk
泌尿生殖上皮-益生菌相互作用的雌激素调节
- 批准号:
7871586 - 财政年份:2010
- 资助金额:
$ 74.83万 - 项目类别:
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk
泌尿生殖上皮-益生菌相互作用的雌激素调节
- 批准号:
8898940 - 财政年份:2010
- 资助金额:
$ 74.83万 - 项目类别:
Estrogenic Modulation of Genitourinary Epithelial-Probiotic Cross-Talk
泌尿生殖上皮-益生菌相互作用的雌激素调节
- 批准号:
8469028 - 财政年份:2010
- 资助金额:
$ 74.83万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related Dementias
慢性创伤性脑病、阿尔茨海默病和阿尔茨海默病相关痴呆的血液生物标记物开发和验证
- 批准号:
10662752 - 财政年份:2023
- 资助金额:
$ 74.83万 - 项目类别:
Bioethical, Legal, and Anthropological Study of Technologies (BLAST)
技术的生物伦理、法律和人类学研究 (BLAST)
- 批准号:
10831226 - 财政年份:2023
- 资助金额:
$ 74.83万 - 项目类别:
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 74.83万 - 项目类别:
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings
一个综合平台,用于在资源匮乏的环境中对癌前和恶性口腔病变进行低成本筛查和图像引导光动力治疗 (PDT)
- 批准号:
10648426 - 财政年份:2023
- 资助金额:
$ 74.83万 - 项目类别:
3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring
3D 力传感鞋垫,用于可穿戴、人工智能支持的高保真步态监控
- 批准号:
10688715 - 财政年份:2023
- 资助金额:
$ 74.83万 - 项目类别: